Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Mental Health

Date Submitted: Oct 20, 2020
Date Accepted: Jan 14, 2021

The final, peer-reviewed published version of this preprint can be found here:

Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale

Owoyemi P, Salcone S, King C, Kim HJ, Ressler KJ, Vahia IV

Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale

JMIR Ment Health 2021;8(4):e25050

DOI: 10.2196/25050

PMID: 33851928

PMCID: 8082386

Measuring and Quantifying Collateral Information in Psychiatry: Feasibility study of the McLean collateral information and clinical actionability scale (M-CICAS)

  • Praise Owoyemi; 
  • Sarah Salcone; 
  • Christopher King; 
  • Heejung Julie Kim; 
  • Kerry James Ressler; 
  • Ipsit Vihang Vahia

ABSTRACT

Background:

The review of collateral information is an essential component of patient care. Though this is standard practice, minimal research has been devoted to quantifying collateral information collection and to understanding how collateral information translates to clinical decision-making. To address this, we developed and piloted a novel measure (the McLean collateral information and clinical actionability scale (M-CICAS)) to evaluate the types and number of collateral sources viewed and resulting actions made in a psychiatric setting.

Objective:

Study aims included: 1) feasibility testing of the M-CICAS measure, 2) validating this measure against clinician notes via medical records, and 3) evaluating whether reviewing a higher volume of collateral sources is associated with more clinical actions taken.

Methods:

For the M-CICAS measure, we developed a three-part instrument, focusing on measuring collateral sources reviewed, clinical actions taken, and shared decision-making between clinician and patient. We recruited clinicians providing psychotherapy services at McLean hospital (N = 7) to complete the M-CICAS measure after individual clinical sessions. We also independently completed the M-CICAS using only the clinician’s corresponding note from that session, in order to validate the reported measure against the electronic health record which served as the objective point of comparison. Based on this, we estimated inter-rater reliability, reporting validity and whether significant variance in clinical actions taken could be attributed to inter-clinician differences.

Results:

Study staff had high interrater reliability on the M-CICAS for the sources reviewed (r=0.98, P<.001) and actions taken (r=0.97, P <.001). Clinician and study staff ratings were moderately correlated and statistically significant on the M-CICAS summary scores for the sources viewed (r’s=0.24 and 0.25, P=.02202 and P=.0188, respectively). Univariate regression modelling demonstrated a significant association between collateral sources and clinical actions taken when clinicians completed the M-CICAS (B=.27, t=2.47, P =.015). Multilevel fixed slopes random intercepts model confirmed a significant association even when accounting for clinician differences (B=.23, t=2.13, P =.037).

Conclusions:

This pilot study establishes feasibility and preliminary validity for the M-CICAS measure in assessing collateral sources and clinical decision-making in psychiatry. This study also indicated that reviewing more collateral sources may lead to an increased number of clinical actions following a session.


 Citation

Please cite as:

Owoyemi P, Salcone S, King C, Kim HJ, Ressler KJ, Vahia IV

Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale

JMIR Ment Health 2021;8(4):e25050

DOI: 10.2196/25050

PMID: 33851928

PMCID: 8082386

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.